A
Research Areas
Links
Biography and Research Information
OverviewAI-generated summary
Alicja Urbaniak's research focuses on investigating the anticancer properties of various compounds and agents. Her work includes studying the in vitro anti-melanoma activity of the Trametes versicolor mushroom, as well as the anti-glioblastoma potential of monensin and its analogs in organoid models. Urbaniak has also investigated modified salinomycin analogs for targeting stem-like cells in breast cancer models and the synthesis and anticancer activity of colchicine derivatives. Additionally, her research has explored the characterization of cannabinoid receptors in Ewing sarcoma cells as potential drug targets and methods for enhancing the effectiveness of virotherapy in pancreatic cancer.
Metrics
- h-index: 15
- Publications: 60
- Citations: 590
Selected Publications
-
Evaluation of the Activity of Monensin and Its Analogs for Modulation of Stem-like Cell Functionality in 2D and 3D Breast Cancer Models (2025)
-
Multimodal reprogramming of the tumor microenvironment by MMR and dual checkpoint blockade in hepatocellular carcinoma models (2025)
-
Pancreatic tumor microenvironment reprogramming via alloantigen-expressing virotherapy elicits tumor rejection and improves immunotherapy response (2025)
-
Monensin and Its Analogs Exhibit Activity Against Breast Cancer Stem-Like Cells in an Organoid Model (2025)
-
Abstract 947: Engineering a synthetic oncolytic virus to overcome apoptotic resistance and induce immunogenic cell death in pancreatic ductal adenocarcinoma (2025)
-
Monensin and Its Analogs Offer a Multi-Targeted Approach to Enhancing Metastatic Breast Cancer Immunogenicity and Cell Death (Abstract ID: 163059) (2025)
-
474 Repositioning monensin: Enhancing anti-cancer activity and immune modulation in breast cancer cells (2025)
-
Enhancing Neoadjuvant Virotherapy’s Effectiveness by Targeting Stroma to Improve Resectability in Pancreatic Cancer (2024)
-
Monensin and its derivatives increase MHC Class I and II presentations in breast cancer (2024)
-
383 Beyond Antibiotics: Monensin and its Derivatives as Promising Anti-Breast Cancer Agents (2024)
-
Synthesis and Anti‐Melanoma Activity of Acryloyl Pyridinone Analogues (2023)
-
Experimental pharmacology in precision medicine (2023)
-
Musashi Exerts Control of Gonadotrope Target mRNA Translation During the Mouse Estrous Cycle (2023)
-
Monensin and its Derivatives Exhibit Anti-Melanoma Activity In Vitro (2023)
-
The mycelium of the Trametes versicolor synn. Coriolus versicolor (Turkey tail mushroom) exhibit anti-melanoma activity in vitro (2023)
Collaboration Network
Top Collaborators
Adam Huczyński
Adam Mickiewicz University in Poznań (PL)
12 shared publications
- Anti-glioblastoma activity of monensin and its analogs in an organoid model of cancer
- Single and double modified salinomycin analogs target stem-like cells in 2D and 3D breast cancer models
- Synthesis, anticancer activity and molecular docking studies of N-deacetylthiocolchicine and 4-iodo-N-deacetylthiocolchicine derivatives
- Abstract PS18-46: Inhibition of breast cancer stem cells in 2- and 3-dimensional culture by novel salinomycin analogs
- Monensin and its analogues show anti‐glioblastoma activity in an organoid model of cancer
Showing 5 of 12 shared publications
Alan J. Tackett
Cancer Institute (WIA)
12 shared publications
In database
- The mycelium of the Trametes versicolor synn. Coriolus versicolor (Turkey tail mushroom) exhibit anti-melanoma activity in vitro
- Anti-glioblastoma activity of monensin and its analogs in an organoid model of cancer
- Synthesis and Anti‐Melanoma Activity of Acryloyl Pyridinone Analogues
- Phosphoproteomics Provides Novel Insights into the Response of Primary Acute Lymphoblastic Leukemia Cells to Microtubule Depolymerization in G1 Phase of the Cell Cycle
- Monensin and its analogues show anti‐glioblastoma activity in an organoid model of cancer
Showing 5 of 12 shared publications
Greta Klejborowska
Adam Mickiewicz University in Poznań (PL)
10 shared publications
- Anti-glioblastoma activity of monensin and its analogs in an organoid model of cancer
- Synthesis, anticancer activity and molecular docking studies of N-deacetylthiocolchicine and 4-iodo-N-deacetylthiocolchicine derivatives
- Monensin and its analogues show anti‐glioblastoma activity in an organoid model of cancer
- Monensin and its Derivatives Exhibit Anti-Melanoma Activity In Vitro
- 383 Beyond Antibiotics: Monensin and its Derivatives as Promising Anti-Breast Cancer Agents
Showing 5 of 10 shared publications
Timothy C. Chambers
University of Arkansas for Medical Sciences
9 shared publications
In database
- Anti-glioblastoma activity of monensin and its analogs in an organoid model of cancer
- Single and double modified salinomycin analogs target stem-like cells in 2D and 3D breast cancer models
- Synthesis, anticancer activity and molecular docking studies of N-deacetylthiocolchicine and 4-iodo-N-deacetylthiocolchicine derivatives
- Primary acute lymphoblastic leukemia cells are susceptible to microtubule depolymerization in G1 and M phases through distinct cell death pathways
- Abstract PS18-46: Inhibition of breast cancer stem cells in 2- and 3-dimensional culture by novel salinomycin analogs
Showing 5 of 9 shared publications
Angus M. MacNicol
University of Arkansas for Medical Sciences
9 shared publications
In database
- Anti-glioblastoma activity of monensin and its analogs in an organoid model of cancer
- Single and double modified salinomycin analogs target stem-like cells in 2D and 3D breast cancer models
- Musashi Exerts Control of Gonadotrope Target mRNA Translation During the Mouse Estrous Cycle
- Abstract PS18-46: Inhibition of breast cancer stem cells in 2- and 3-dimensional culture by novel salinomycin analogs
- Monensin and its analogues show anti‐glioblastoma activity in an organoid model of cancer
Showing 5 of 9 shared publications
Marta Jędrzejczyk
Adam Mickiewicz University in Poznań (PL)
9 shared publications
- Anti-glioblastoma activity of monensin and its analogs in an organoid model of cancer
- Monensin and its analogues show anti‐glioblastoma activity in an organoid model of cancer
- Monensin and its Derivatives Exhibit Anti-Melanoma Activity In Vitro
- 383 Beyond Antibiotics: Monensin and its Derivatives as Promising Anti-Breast Cancer Agents
- Monensin and its derivatives increase MHC Class I and II presentations in breast cancer
Showing 5 of 9 shared publications
Natalia Stępczyńska
Adam Mickiewicz University in Poznań (PL)
9 shared publications
- Anti-glioblastoma activity of monensin and its analogs in an organoid model of cancer
- Monensin and its analogues show anti‐glioblastoma activity in an organoid model of cancer
- Monensin and its Derivatives Exhibit Anti-Melanoma Activity In Vitro
- 383 Beyond Antibiotics: Monensin and its Derivatives as Promising Anti-Breast Cancer Agents
- Monensin and its derivatives increase MHC Class I and II presentations in breast cancer
Showing 5 of 9 shared publications
Billie Heflin
University of Arkansas for Medical Sciences
8 shared publications
In database
- The mycelium of the Trametes versicolor synn. Coriolus versicolor (Turkey tail mushroom) exhibit anti-melanoma activity in vitro
- Anti-glioblastoma activity of monensin and its analogs in an organoid model of cancer
- Primary acute lymphoblastic leukemia cells are susceptible to microtubule depolymerization in G1 and M phases through distinct cell death pathways
- Synthesis and Anti‐Melanoma Activity of Acryloyl Pyridinone Analogues
- Phosphoproteomics Provides Novel Insights into the Response of Primary Acute Lymphoblastic Leukemia Cells to Microtubule Depolymerization in G1 Phase of the Cell Cycle
Showing 5 of 8 shared publications
Thomas J. Kelly
University of Arkansas for Medical Sciences
8 shared publications
In database
- Enhancing Neoadjuvant Virotherapy’s Effectiveness by Targeting Stroma to Improve Resectability in Pancreatic Cancer
- 383 Beyond Antibiotics: Monensin and its Derivatives as Promising Anti-Breast Cancer Agents
- Monensin and its derivatives increase MHC Class I and II presentations in breast cancer
- 474 Repositioning monensin: Enhancing anti-cancer activity and immune modulation in breast cancer cells
- Monensin and Its Analogs Offer a Multi-Targeted Approach to Enhancing Metastatic Breast Cancer Immunogenicity and Cell Death (Abstract ID: 163059)
Showing 5 of 8 shared publications
Steven R. Post
Winthrop Rockefeller Foundation
8 shared publications
In database
- Enhancing Neoadjuvant Virotherapy’s Effectiveness by Targeting Stroma to Improve Resectability in Pancreatic Cancer
- 474 Repositioning monensin: Enhancing anti-cancer activity and immune modulation in breast cancer cells
- Monensin and Its Analogs Offer a Multi-Targeted Approach to Enhancing Metastatic Breast Cancer Immunogenicity and Cell Death (Abstract ID: 163059)
- Abstract 947: Engineering a synthetic oncolytic virus to overcome apoptotic resistance and induce immunogenic cell death in pancreatic ductal adenocarcinoma
- Monensin and Its Analogs Exhibit Activity Against Breast Cancer Stem-Like Cells in an Organoid Model
Showing 5 of 8 shared publications
Megan R. Reed
University of Arkansas for Medical Sciences
7 shared publications
In database
- Anti-glioblastoma activity of monensin and its analogs in an organoid model of cancer
- Single and double modified salinomycin analogs target stem-like cells in 2D and 3D breast cancer models
- Primary acute lymphoblastic leukemia cells are susceptible to microtubule depolymerization in G1 and M phases through distinct cell death pathways
- Abstract PS18-46: Inhibition of breast cancer stem cells in 2- and 3-dimensional culture by novel salinomycin analogs
- Monensin and its analogues show anti‐glioblastoma activity in an organoid model of cancer
Showing 5 of 7 shared publications
Melanie C MacNicol
University of Arkansas for Medical Sciences
7 shared publications
In database
- Single and double modified salinomycin analogs target stem-like cells in 2D and 3D breast cancer models
- Musashi Exerts Control of Gonadotrope Target mRNA Translation During the Mouse Estrous Cycle
- Abstract PS18-46: Inhibition of breast cancer stem cells in 2- and 3-dimensional culture by novel salinomycin analogs
- RF01 | PMON46 Regulation of the Pituitary Cell Lineage Regulator Prop1 by the Stem Cell Determinant Musashi
- RF25 | PMON50 Insight into Integrated Control of Pituitary Function Revealed Through Analysis of Musashi Target mRNAs
Showing 5 of 7 shared publications
Robert L. Eoff
University of Arkansas for Medical Sciences
6 shared publications
In database
- Anti-glioblastoma activity of monensin and its analogs in an organoid model of cancer
- Single and double modified salinomycin analogs target stem-like cells in 2D and 3D breast cancer models
- Abstract PS18-46: Inhibition of breast cancer stem cells in 2- and 3-dimensional culture by novel salinomycin analogs
- Monensin and its analogues show anti‐glioblastoma activity in an organoid model of cancer
- Monensin and Its Analogs Exhibit Activity Against Breast Cancer Stem-Like Cells in an Organoid Model
Showing 5 of 6 shared publications
Bolni Marius Nagalo
University of Arkansas for Medical Sciences
6 shared publications
In database
- Enhancing Neoadjuvant Virotherapy’s Effectiveness by Targeting Stroma to Improve Resectability in Pancreatic Cancer
- Monensin and its derivatives increase MHC Class I and II presentations in breast cancer
- 474 Repositioning monensin: Enhancing anti-cancer activity and immune modulation in breast cancer cells
- Monensin and Its Analogs Offer a Multi-Targeted Approach to Enhancing Metastatic Breast Cancer Immunogenicity and Cell Death (Abstract ID: 163059)
- Pancreatic tumor microenvironment reprogramming via alloantigen-expressing virotherapy elicits tumor rejection and improves immunotherapy response
Showing 5 of 6 shared publications
Eric R. Siegel
Winthrop Rockefeller Foundation
5 shared publications
In database
- 474 Repositioning monensin: Enhancing anti-cancer activity and immune modulation in breast cancer cells
- Monensin and Its Analogs Offer a Multi-Targeted Approach to Enhancing Metastatic Breast Cancer Immunogenicity and Cell Death (Abstract ID: 163059)
- Monensin and Its Analogs Exhibit Activity Against Breast Cancer Stem-Like Cells in an Organoid Model
- Pancreatic tumor microenvironment reprogramming via alloantigen-expressing virotherapy elicits tumor rejection and improves immunotherapy response
- Evaluation of the Activity of Monensin and Its Analogs for Modulation of Stem-like Cell Functionality in 2D and 3D Breast Cancer Models
Similar Researchers
Based on overlapping research topics
Gretchen Holtgrefe
University of Arkansas for Medical Sciences
Cancer Treatment and Pharmacology
Pharmacological Effects and Toxicity Studies
Disease Mechanisms Research
Alexei G. Basnakian
University of Arkansas for Medical Sciences
Cancer Treatment and Pharmacology
Pharmacological Effects and Toxicity Studies
Cancer-related molecular mechanisms research
Li Pang
National Center for Toxicological Research
Cancer Treatment and Pharmacology
Pharmacological Effects and Toxicity Studies
Drug Delivery Systems
Paul D. Adams
University of Arkansas at Fayetteville
Cancer Treatment and Pharmacology
Cancer-related molecular mechanisms research
Drug Delivery Systems
Gunaganti Naresh
University of Arkansas for Medical Sciences
Cancer Treatment and Pharmacology
Drug Delivery Systems
Computational Drug Discovery Methods
Li Han
University of Arkansas for Medical Sciences
Cancer Treatment and Pharmacology
Pharmacological Effects and Toxicity Studies
Cancer-related molecular mechanisms research